Zacks Investment Research on MSN
Rezolute stock gains after FDA meeting on Ersodetug program update
Shares of Rezolute RZLT gained 12.1% on Tuesday after the company announced productive outcomes from an in-person Type B ...
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) ...
The Iowa State University Faculty Senate held a short meeting Tuesday, lasting 45 minutes, to discuss the approval of new academic certificates and program name changes, the introduction of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results